anti-CD19 UCAR-NK cells

BIOLOGICAL2 trials

Sponsors

Kunming Hope of Health Hospital, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

Conditions

B-Cell Lymphoblastic Leukemia/LymphomaB-cell LeukemiaB-cell Lymphoma

Phase 1

Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies

WithdrawnNCT05570188

Kunming Hope of Health HospitalB-cell Leukemia, B-cell Lymphoma

Start: 2022-10-01End: 2025-10-31Updated: 2022-11-30

A Study of Universal CD19-Targeted UCAR-NK Cells Combined With HSCT for B Cell Hematologic Malignancies

920th Hospital of Joint Logistics Support Force of People's Liberation Army of ChinaB-Cell Lymphoblastic Leukemia/Lymphoma

Start: 2022-12-08End: 2024-12-31Target: 30Updated: 2022-12-21